GIVEAWAY with @pulsepot!
⭐️ 150k HEX giveaway ⭐️
- (50k #HEX each, 3 different winners)
All you have to do is:
⁃Like and retweet this post
The winners will be chosen July 31st, 2022❤️ this community is the sickest.
good luck 🍀
#HEX#PulseChain#PulseX
The COSMIC-021 trial showed activity w/ cabozantinib plus atezolizumab in pts w/ locally advanced or mCRPC who have been previously treated, including patients with high-risk features. @neerajaiims@huntsmancancer@myESMO#ESMO2021#lcsm https://t.co/dbYxkAEUY3
1/ On the heels of @ASCO#ASCO21 plenary, we are happy to share the results of KEYNOTE-564 trial of adjuvant pembrolizumab in mRCC just published in @NEJM ! A step towards better outcomes for all our patients with kidney cancer!
https://t.co/QWDp5ADD0x
@OncoAlert@tompowles1
Another amazing class of oncologists goes out into the world! We are proud of each of you and can’t wait to see you all succeed in your lives and career. 😍💖Presenting the 🎓 2021 @UABHemOncFellow Graduates!!! 🥂🎉 Drs. Sampat,Outlaw, Rangarajan and Bodine
We had a blast today celebrating with our graduating class of 2021 🥳@UABHemOncFellow at @VABIRMINGHAM 🎓💖🙏🏽🤩 We are so proud of each and every one of you and wish you the best in life!!!
Checkmate 649 published! @sloan_kettering ✅ @KoheiShitara #ASCO21 @ASCO Leading Phase III studies is fun! Thank you to all the patients and caregivers, to my amazing colleagues and @bmsnews @ScienceAtBMS https://t.co/oOAc5CRTpJ
Today we celebrate. Tomorrow we conquer. Funding is the 1st step toward a breakthrough. Give to the #ASCOCONQUERSCANCER Fund during #ASCO21. Support researchers like these & their work to help patients everywhere https://t.co/NUvFdWLWY7